Source: Chirality. Unidades: FCFRP, FCF
Subjects: FARMACOLOGIA, FARMACOCINÉTICA, METABOLISMO, CISTICERCOSE
ABNT
MARQUES, Maria Paula da Costa et al. Enantioselective kinetic disposition of albendazole sulfoxide in patients with neurocysticercosis. Chirality, v. 11, n. 3, p. 218-233, 1999Tradução . . Disponível em: https://doi.org/10.1002/(sici)1520-636x(1999)11:3%3C218::aid-chir8%3E3.0.co;2-g. Acesso em: 19 out. 2024.APA
Marques, M. P. da C., Takayanagui, O. M., Bonato, P. S., Santos, S. R. C. J., & Lanchote, V. L. (1999). Enantioselective kinetic disposition of albendazole sulfoxide in patients with neurocysticercosis. Chirality, 11( 3), 218-233. doi:10.1002/(sici)1520-636x(1999)11:3%3C218::aid-chir8%3E3.0.co;2-gNLM
Marques MP da C, Takayanagui OM, Bonato PS, Santos SRCJ, Lanchote VL. Enantioselective kinetic disposition of albendazole sulfoxide in patients with neurocysticercosis [Internet]. Chirality. 1999 ; 11( 3): 218-233.[citado 2024 out. 19 ] Available from: https://doi.org/10.1002/(sici)1520-636x(1999)11:3%3C218::aid-chir8%3E3.0.co;2-gVancouver
Marques MP da C, Takayanagui OM, Bonato PS, Santos SRCJ, Lanchote VL. Enantioselective kinetic disposition of albendazole sulfoxide in patients with neurocysticercosis [Internet]. Chirality. 1999 ; 11( 3): 218-233.[citado 2024 out. 19 ] Available from: https://doi.org/10.1002/(sici)1520-636x(1999)11:3%3C218::aid-chir8%3E3.0.co;2-g